Gregory Ian Frost Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gregory Ian Frost.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gregory Ian Frost. Gregory Ian Frost is VP and Chief Scientific Off. in HALOZYME THERAPEUTICS INC ($GYHT).
Latest Insider Trading Transactions of Gregory Ian Frost
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 09 2009 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | A | 6.10 | 80,000 | 488,000 | 257,480 | |
| Mar 24 2008 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 6.06 | 230,000 | 1,393,800 | 3,530,866 | 3.8 M to 3.5 M (-6.12 %) |
| Mar 21 2008 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 639,902 | 275,158 | 177,480 | |
| Mar 21 2008 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 6.06 | 28,642 | 173,571 | 3,760,866 | 3.8 M to 3.8 M (-0.76 %) |
| Mar 21 2008 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 639,902 | 275,158 | 3,789,508 | 3.1 M to 3.8 M (+20.32 %) |
| Feb 08 2008 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | A | 5.60 | 50,000 | 280,000 | 747,141 | |
| Dec 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 9,736 | 4,186 | 697,141 | |
| Dec 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.00 | 9,137 | 63,959 | 3,149,606 | 3.2 M to 3.1 M (-0.29 %) |
| Dec 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 6.98 | 599 | 4,181 | 3,158,743 | 3.2 M to 3.2 M (-0.02 %) |
| Dec 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 9,736 | 4,186 | 3,159,342 | 3.1 M to 3.2 M (+0.31 %) |
| Dec 12 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 42,760 | 18,387 | 706,877 | |
| Dec 12 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 6.66 | 2,760 | 18,382 | 3,149,606 | 3.2 M to 3.1 M (-0.09 %) |
| Dec 12 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 42,760 | 18,387 | 3,152,366 | 3.1 M to 3.2 M (+1.38 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 10,603 | 4,559 | 749,637 | |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.82 | 100 | 782 | 3,109,606 | 3.1 M to 3.1 M (0.00 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.81 | 400 | 3,124 | 3,109,706 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.78 | 300 | 2,334 | 3,110,106 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.77 | 300 | 2,331 | 3,110,406 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.73 | 200 | 1,546 | 3,110,706 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.72 | 200 | 1,544 | 3,110,906 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.71 | 900 | 6,939 | 3,111,106 | 3.1 M to 3.1 M (-0.03 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.66 | 200 | 1,532 | 3,112,006 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.65 | 200 | 1,530 | 3,112,206 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.63 | 700 | 5,341 | 3,112,406 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.62 | 600 | 4,572 | 3,113,106 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.61 | 400 | 3,044 | 3,113,706 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.60 | 600 | 4,560 | 3,114,106 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.59 | 800 | 6,072 | 3,114,706 | 3.1 M to 3.1 M (-0.03 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.58 | 900 | 6,822 | 3,115,506 | 3.1 M to 3.1 M (-0.03 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.57 | 1,600 | 12,112 | 3,116,406 | 3.1 M to 3.1 M (-0.05 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.56 | 166 | 1,255 | 3,118,006 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.55 | 300 | 2,265 | 3,118,172 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.54 | 834 | 6,288 | 3,118,472 | 3.1 M to 3.1 M (-0.03 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.51 | 300 | 2,253 | 3,119,306 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 7.56 | 603 | 4,559 | 3,119,606 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 10,603 | 4,559 | 3,120,209 | 3.1 M to 3.1 M (+0.34 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.07 | 500 | 4,035 | 3,109,606 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.06 | 300 | 2,418 | 3,110,106 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.02 | 800 | 6,416 | 3,110,406 | 3.1 M to 3.1 M (-0.03 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.01 | 300 | 2,403 | 3,111,206 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 12,374 | 5,321 | 760,240 | |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.00 | 500 | 4,000 | 3,111,506 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.99 | 200 | 1,598 | 3,112,006 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.98 | 400 | 3,192 | 3,112,206 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.97 | 500 | 3,985 | 3,112,606 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.96 | 600 | 4,776 | 3,113,106 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.94 | 600 | 4,764 | 3,113,706 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.93 | 900 | 7,137 | 3,114,306 | 3.1 M to 3.1 M (-0.03 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.92 | 100 | 792 | 3,115,206 | 3.1 M to 3.1 M (0.00 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.91 | 100 | 791 | 3,115,306 | 3.1 M to 3.1 M (0.00 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.90 | 400 | 3,160 | 3,115,406 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.88 | 300 | 2,364 | 3,115,806 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.87 | 600 | 4,722 | 3,116,106 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.86 | 200 | 1,572 | 3,116,706 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.84 | 500 | 3,920 | 3,116,906 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.82 | 400 | 3,128 | 3,117,406 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.80 | 400 | 3,120 | 3,117,806 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.79 | 200 | 1,558 | 3,118,206 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.76 | 200 | 1,552 | 3,118,406 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.75 | 300 | 2,325 | 3,118,606 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.72 | 300 | 2,316 | 3,118,906 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.71 | 100 | 771 | 3,119,206 | 3.1 M to 3.1 M (0.00 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.69 | 300 | 2,307 | 3,119,306 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.68 | 87 | 668 | 3,119,606 | 3.1 M to 3.1 M (0.00 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.65 | 200 | 1,530 | 3,119,693 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.63 | 400 | 3,052 | 3,119,893 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.62 | 613 | 4,671 | 3,120,293 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.61 | 100 | 761 | 3,120,906 | 3.1 M to 3.1 M (0.00 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.57 | 300 | 2,271 | 3,121,006 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 7.87 | 674 | 5,304 | 3,121,306 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 12,374 | 5,321 | 3,121,980 | 3.1 M to 3.1 M (+0.40 %) |
| Nov 13 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 42,340 | 18,206 | 772,614 | |
| Nov 13 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 7.78 | 2,340 | 18,205 | 3,109,606 | 3.1 M to 3.1 M (-0.08 %) |
| Nov 13 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 42,340 | 18,206 | 3,111,946 | 3.1 M to 3.1 M (+1.38 %) |
Page: 1